Martin Madaus - Jun 14, 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Jun 14, 2024
Transactions value $
$201,776
Form type
4
Date filed
6/14/2024, 06:07 PM
Previous filing
May 20, 2024
Next filing
Nov 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Purchase $114K +915 +30.52% $124.54 3.91K Jun 14, 2024 Direct F1, F3
transaction RGEN Common Stock Purchase $87.8K +700 +17.89% $125.46 4.61K Jun 14, 2024 Direct F2, F3
holding RGEN Common Stock 11 Jun 14, 2024 Spouse Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $124.54 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $124.25 to $125.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.
F2 $125.46 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $125.25 to $125.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.
F3 Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.